|
|
|
Volumn 99 Suppl 4, Issue , 2008, Pages 14-22
|
|
Infectious risk;Riesgo infeccioso.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
DERMATOLOGICAL AGENT;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ARTICLE;
DRUG ANTAGONISM;
FOLLOW UP;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
POSTMARKETING SURVEILLANCE;
PSORIASIS;
PSORIATIC ARTHRITIS;
RISK FACTOR;
TIME;
TUBERCULOSIS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, PSORIATIC;
DERMATOLOGIC AGENTS;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSION;
INFECTION;
PRODUCT SURVEILLANCE, POSTMARKETING;
PSORIASIS;
RISK FACTORS;
TIME FACTORS;
TUBERCULOSIS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 58749088079
PISSN: 00017310
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
